The Coordination Team of the IFIGENEIA Project (Prof. Chara Petridou, Prof. Dimos Sampsonidis, Dr Yannis Papaphilippou and Dr. Fanouria Antoniou) carried out a visit to the German Cancer Research Center (DKFZ), marking an important milestone in the implementation of...
Preserving cultural heritage while embracing cutting-edge research, the Archaeological Museum of Thessaloniki plays a unique role at the intersection of archaeology, science, and innovation. Archaeological Museum of Thessaloniki (AMTH) is one of the largest museums in...
The EANM 2025 congress in Barcelona (Spain) confirmed that nuclear medicine is moving from rapid expansion into a phase of consolidation, shaped by theranostics, isotope availability, and translation into routine clinical use. With nearly 10,000 participants from more...
Putting patients, prevention, and public trust at the heart of cancer care, the Cyprus Association of Cancer Patients & Friends (PASYKAF) has been a key advocate for people affected by cancer for decades, both nationally and internationally. PASYKAF is a...
Cosylab d.d. supports cutting-edge accelerator-based technologies worldwide—from Big Science facilities to advanced medical applications—and brings this same end-to-end expertise to IFIGENEIA’s work on radioisotope production and radiopharmaceuticals. Cosylab d.d. is...
IFIGENEIA is proud to be an organiser of a ten-day event, a challenge based on innovations for students - CBI, that will be held at the University of Sarajevo. The goal is to present an innovative idea on the use of accelerators in applications that benefit the wider...
The IFIGENEIA project (Horizon Europe, WIDERA) aims to lay the foundations for significant advancements in the production and clinical application of radionuclides using linear accelerators (LINACs), thereby enhancing radiopharmaceutical development and availability...
BIOKOSMOS MEDICAL SCIENTIFIC EQUIPMENT COMMERCIAL INDUSTRY SOCIETE ANONYME, (BIOKOSMOS SA, a pioneering Greek company in the field of radiopharmaceuticals and molecular imaging, brings decades of expertise, advanced technological infrastructure, and strong research...
The University of Cyprus (UCY) is a major academic and research institution in the Eastern Mediterranean region, with a strong strategic role in advancing education, training, and capacity building within the IFIGENEIA project. Through its established excellence in...
The Jožef Stefan Institute is Slovenia’s leading scientific research institute dedicated to science and technology, covering a broad spectrum of basic and applied research. With strong international collaboration and a clear mission to generate new knowledge, develop...
In September 2025 World Health Organization (WHO) published results of an extensive analysis, Cancer research and development landscape: overview of 1999-2022 period. The report presents interesting insights and findings for cancer treatment, based on 112 899...
The Sarajevo Medical School of the University Sarajevo School of Science and Technology (SSST) recently had the honour of hosting Dr. Yiota Foka, senior scientist at the GSI Helmholtz Centre for Heavy Ion Research in Darmstadt and CERN collaborator, for an inspiring...
As a key public authority in Northern Greece, the Region of Central Macedonia contributes strategic insight and regional expertise to support the sustainability and long-term impact of the IFIGENEIA project. The Region of Central Macedonia (RCM) is one of the thirteen...
IFIGENEIA mentoring event at the UNSA Department of PhysicsA special interactive event, within the IFIGENEIA mentoring scheme, was organized for students of the Department of Physics at the University of Sarajevo, on October 10th 2025. The event was based on the...
With strong experience at the intersection of policy, innovation, and business development, RTD Talos contributes essential expertise to strengthening the long-term impact and sustainability of the IFIGENEIA project. RTD Talos was established in September 2000, at a...
The 22nd European Symposium on Radiopharmacy and Radiochemistry (ESRR 2026) will be held in Bergen, Norway, on 16–19 April 2026. The symposium focuses on radionuclide production, radiochemistry, radiopharmaceutical development, radiobiology, and clinical translation....
The 21st European Molecular Imaging Meeting (EMIM 2026) will be held on 24–27 March in Ljubljana, Slovenia, at Cankarjev Dom. The meeting brings together about 1,200 researchers working in morphological, functional, and molecular imaging, from mass spectrometry and...
May health and science come together for a brighter future in 2026! Warm holiday wishes from IFIGENEIA!
With a strong interdisciplinary foundation and decades of scientific excellence, the University of Ljubljana brings valuable expertise to the IFIGENEIA consortium, contributing to the project’s vision of advancing next-generation radioisotope technologies. The...
In November 2025, Prof. Dr. DABR. Joao Seco held several lectures and presentations in Slovenia about cancer treatments from different perspectives. In the scope of his visit, he also shared his insights on how cancer research has developed in the past years and...
As one of Europe’s leading academic institutions, the Aristotle University of Thessaloniki (AUTH) plays a pivotal role in driving scientific excellence and innovation within the IFIGENEIA project. With its strong multidisciplinary foundation and longstanding research...
The co-organiser of the Aristotle Medical Forum 2024, in Thessaloniki, Prof Panagiotis Bamidis, President of the Hellenic Society of Biomedical Technology and head of the Medical Physics and Digital Innovation Lab of the School of Medicine of the Aristotle University...
In the scope of the IFIGENEIA project, we hosted an invited lecture by Prof. Dr. DABR. Joao Seco on 11 November 2025 at the Faculty of Medicine, University of Ljubljana, Slovenia, on the topic: Next generation technologies that can impact cancer therapy: FLASH, SFRT...
During the COVID-19 pandemic, mRNA vaccines became widely known to the general public. With their use, the immune system could recognise the virus and start creating antibodies to fight it. More precisely, mRNA (messenger ribonucleic acid) taught the immune system to...
Slovenian partners of the IFIGENEIA project.Slovenian partners of the European project IFIGENEIA held their first meeting of the Slovenian Hub (SLO HUB) in Ljubljana earlier this spring, bringing together key stakeholders from nuclear physics, medical physics,...
Cancer is the second leading cause of death in Europe. Moreover, it's the leading cause of death for women and men under 65. In 2022, new cancer cases reached 2.7 million and the incidence increased for 2.3% in comparison with 2020. In the same period, estimated...
In the scope of the IFIGENEIA project invited lecture Next Generation Technologies that can Impact Cancer Therapy: FLASH, SFRT and TRNT was held on Tuesday 11 November 2025 at the Faculty of Medicine (University of Ljubljana). In the introduction Prof. Dr. DABR. Joao...
According to the World Cancer Research Fund the prostate and testicular cancers were 4th and 27th most common cancers worldwide in 2022, with more than 1.4 million and 72,000 new cases discovered. The month November is now for more than 2 decades dedicated to raising...
Invited lecture: Next generation technologies that can impact cancer therapy: FLASH, SFRT and TRNT Date and Time: Tuesday, 11 November 2025, at 11.00-12.00 CET Venue: Faculty of Medicine, University of Ljubljana, Lecture hall MP, Korytkova 2, 1000 Ljubljana Invited...
The IFIGENEIA Horizon project was presented to the public of Bosnia and Herzegovina at three official events during the month of September 2025. As a keynote speaker, invited in Sarajevo, at the 6th International Science and Business Conference – CMBEBIH 2025 – Dr....
On 29th September, 2025, the first meeting of the Cyprus Hub of the European Project IFIGENEIA was held, in Nicosia, with the aim of communicating the Project to relevant stakeholders. The event brought together representatives from the Ministry of Health, the...
The IFIGENEIA project – Innovative Facility for Isotope GENeration with Efficient Ion Accelerator – is a European initiative funded by the Horizon Europe programme. It aims to transform how medical radioisotopes are produced and distributed, ensuring that future...
In May 2025, the University of Sarajevo welcomed representatives of the European Organization for Nuclear Research (CERN), researchers Dr. Tadeusz Kurtyka and Dr. Claude Charlot. On behalf of the University of Sarajevo, Rector Prof. Dr. Tarik Zaimović extended a warm...
The four-year international project IFIGENEIA (Excellence Hub for LINAC-based Innovation in Nuclear Medicine) was officially launched with a kick-off meeting in early April 2025 in Thessaloniki, Greece. The project brings together 22 partners from six...